These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8615009)
21. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. Zheng Y; Li J; Ou JH J Virol; 2004 Jul; 78(13):6908-14. PubMed ID: 15194767 [TBL] [Abstract][Full Text] [Related]
22. The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53. Schmidt T; Körner K; Karsunky H; Korsmeyer S; Müller R; Möröy T Cell Death Differ; 1999 Sep; 6(9):873-82. PubMed ID: 10510469 [TBL] [Abstract][Full Text] [Related]
23. E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter. Choi M; Lee H; Rho HM IUBMB Life; 2002 Jun; 53(6):309-17. PubMed ID: 12625370 [TBL] [Abstract][Full Text] [Related]
24. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type. Thomas S; Reisman D Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433 [TBL] [Abstract][Full Text] [Related]
25. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma. Lee YI; Lee S; Das GC; Park US; Park SM; Lee YI Oncogene; 2000 Aug; 19(33):3717-26. PubMed ID: 10949925 [TBL] [Abstract][Full Text] [Related]
26. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Lara-Pezzi E; Majano PL; Gómez-Gonzalo M; García-Monzón C; Moreno-Otero R; Levrero M; López-Cabrera M Hepatology; 1998 Oct; 28(4):1013-21. PubMed ID: 9755238 [TBL] [Abstract][Full Text] [Related]
27. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970 [TBL] [Abstract][Full Text] [Related]
28. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946 [TBL] [Abstract][Full Text] [Related]
29. Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways. Kühnel F; Zender L; Wirth T; Schulte B; Trautwein C; Manns M; Kubicka S Cancer Gene Ther; 2004 Jan; 11(1):28-40. PubMed ID: 14681724 [TBL] [Abstract][Full Text] [Related]
30. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription. Innocente SA; Lee JM FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382 [TBL] [Abstract][Full Text] [Related]
31. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct. Lin Y; Nomura T; Yamashita T; Dorjsuren D; Tang H; Murakami S Cancer Res; 1997 Nov; 57(22):5137-42. PubMed ID: 9371515 [TBL] [Abstract][Full Text] [Related]
32. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1. Zhou D; Masri S; Ye JJ; Chen S Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749 [TBL] [Abstract][Full Text] [Related]
33. Human p53 binds DNA as a protein homodimer but monomeric variants retain full transcription transactivation activity. Tarunina M; Jenkins JR Oncogene; 1993 Nov; 8(11):3165-73. PubMed ID: 8414520 [TBL] [Abstract][Full Text] [Related]
34. Transactivation of cellular promoters by an integrated hepatitis B virus DNA. Yamamoto S; Nakatake H; Kawamoto S; Takimoto M; Koshy R; Matsubara K Biochem Biophys Res Commun; 1993 Apr; 192(1):111-8. PubMed ID: 8476412 [TBL] [Abstract][Full Text] [Related]
35. Novel DNA binding of p53 mutants and their role in transcriptional activation. Zhang W; Funk WD; Wright WE; Shay JW; Deisseroth AB Oncogene; 1993 Sep; 8(9):2555-9. PubMed ID: 8361764 [TBL] [Abstract][Full Text] [Related]
36. Release of the p53-induced repression on thymidine kinase promoter by single p53-binding sequence. Yuan JN; Liu BH; Lee H; Shaw YT; Chiou ST; Chang WC; Lai MD Biochem Biophys Res Commun; 1993 Mar; 191(2):662-8. PubMed ID: 8384849 [TBL] [Abstract][Full Text] [Related]
37. Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death. Takada S; Shirakata Y; Kaneniwa N; Koike K Oncogene; 1999 Nov; 18(50):6965-73. PubMed ID: 10597295 [TBL] [Abstract][Full Text] [Related]
38. p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53. Ori A; Zauberman A; Doitsh G; Paran N; Oren M; Shaul Y EMBO J; 1998 Jan; 17(2):544-53. PubMed ID: 9430645 [TBL] [Abstract][Full Text] [Related]